 Dorman Products Inc NASDAQ: DORM reported second-quarter FY21 sales growth of 33 year-on-year, to 310.6 million, beating the analyst consensus of 287.87 million. The company attributed the revenue growth to the absence of government-imposed shut-downs that negatively impacted the previous years results. 